Stelexis Therapeutics
Phase 1Stelexis BioSciences is a clinical-stage biopharmaceutical company created to accelerate novel treatments that aim to eradicate hematological cancers at their root causes to drive better outcomes for patients.
Founded
2018
Focus
Small Molecules
About
Stelexis BioSciences is a clinical-stage biopharmaceutical company created to accelerate novel treatments that aim to eradicate hematological cancers at their root causes to drive better outcomes for patients.
Funding History
2Total raised: $73M
Series A$65MAtlas VentureApr 15, 2023
Seed$8MAtlas VentureJan 15, 2022
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile